Neon Therapeutics

Neon Therapeutics company information, Employees & Contact Information

Updated June 2026

Quick answer

Neon Therapeutics is a Biotechnology Research company and founded in 2015. It has approximately 15 employees on record. Contact data was last refreshed in June 2026. Find Neon Therapeutics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Neon Therapeutics is a clinical-stage immuno-oncology company and a leader in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. For more information, please visit https://neontherapeutics.com/ and follow us on Twitter @Neon_Tx.

Company Details

Employees
15
Founded
2015
Address
40 Erie St, Cambridge,massachusetts 02139,united States
Phone
(617)337-4701
Email
in****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Cambridge, Massachusetts
Looking for a particular Neon Therapeutics employee's phone or email?

Neon Therapeutics Questions

News

BioNTech to acquire Neon to strengthen global leadership position in T cell therapies - GlobeNewswire

BioNTech to acquire Neon to strengthen global leadership position in T cell therapies GlobeNewswire

After IPO, BioNTech nabs cell therapy startup Neon Therapeutics - Fierce Biotech

After IPO, BioNTech nabs cell therapy startup Neon Therapeutics Fierce Biotech

Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role - PMLiVE

Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role PMLiVE

Neon Therapeutics Announces New Strategic Focus on Novel T Cell Programs - GlobeNewswire

Neon Therapeutics Announces New Strategic Focus on Novel T Cell Programs GlobeNewswire

Immuno-oncology player Neon Therapeutics looks for $115M in IPO - Fierce Biotech

Immuno-oncology player Neon Therapeutics looks for $115M in IPO Fierce Biotech

Neon Therapeutics' neoantigen vaccine boosts Opdivo response in 3 cancers - Fierce Biotech

Neon Therapeutics' neoantigen vaccine boosts Opdivo response in 3 cancers Fierce Biotech

Neon Therapeutics Announces Closing of Initial Public Offering - GlobeNewswire

Neon Therapeutics Announces Closing of Initial Public Offering GlobeNewswire

Top Neon Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant